Skip to content

US · AMN · MEDICAL - CARE FACILITIES

AMN Healthcare Services, Inc. (AMN) intrinsic value and stock valuation

$35.68as of 2026-11-21 · Mkt cap 1.27B

Data updated · price as of 2026-11-21

Fairly valuedIC value is within 20% of the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

AMN Healthcare Services, Inc. DCF and intrinsic value

InvestorsCraft values AMN with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from AMN’s statements →

AMN Healthcare Services, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Care Facilities Dallas, TX 75019 amnhealthcare.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$2.73B+2.7% 5y CAGRd
20112025
Net income
-$-95.7M
20112025
Free cash flow
$233.8M+1.4% 5y CAGRd
20112025
Total equity
$642.1M-4.8% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$2.73B$2.98B$3.79B$5.24B$3.98B
Operating income$33.2M-$-102.67M$338.4M$647.1M$478M
Net income-$-95.7M-$-146.98M$210.7M$444.1M$327.4M
EPSd-$-2.48M-$-3.85M$5.36M$9.9M$6.81M
Operating cash flow$269.5M$320.4M$372.2M$653.7M$305.4M
Capital expenditure-$-35.63M-$-80.89M-$-105.39M-$-80.92M-$-53.66M
Free cash flow$233.8M$239.5M$266.8M$572.8M$251.7M
Total assets$2.09B$2.42B$2.92B$2.89B$3.13B
Total debt$803.2M$1.1B$1.35B$861M$867.1M
Net debt$769.2M$1.09B$1.32B$796.4M$686.1M
Total equity$642.1M$706.6M$831.3M$1.04B$1.16B
Cash and short-term investments$34M$10.7M$32.9M$64.5M$180.9M
Income statement
20252024202320222021
Revenue$2.73B$2.98B$3.79B$5.24B$3.98B
Cost of revenue$1.96B$2.06B$2.54B$3.53B$2.67B
Gross profit$774.1M$919.4M$1.25B$1.72B$1.31B
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$593M$632.5M$756.2M$936.6M$730.5M
Other expenses$147.9M$389.6M$154.9M$133M$101.2M
Operating expenses$740.9M$1.02B$911.2M$1.07B$831.6M
Cost and expenses$2.7B$3.09B$3.45B$4.6B$3.51B
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$45.6M$69.9M$54.1M$40.4M$34.1M
Depreciation and amortization$156.6M$173.8M$160.9M$137.1M$103.7M
Ebitda$101.1M$71.1M$499.4M$784.2M$581.7M
Operating income$33.2M-$-102.67M$338.4M$647.1M$478M
Total other income/expenses, net-$-134.23M-$-69.9M-$-54.14M-$-40.4M-$-34.08M
Income before tax-$-101.06M-$-172.57M$284.3M$606.7M$443.9M
Income tax expense-$-5.36M-$-25.59M$73.6M$162.7M$116.5M
Net income-$-95.7M-$-146.98M$210.7M$444.1M$327.4M
Weighted average shares outstanding$38.5M$38.2M$39.2M$44.6M$47.7M
Weighted average diluted shares outstanding$38.5M$38.2M$39.3M$44.9M$48.1M
Balance sheet
20252024202320222021
Cash and short-term investments$34M$10.7M$32.9M$64.5M$180.9M
Net receivables$439.1M$520M$746.5M$953.3M$1.03B
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$545.4M$594.9M$841.7M$1.09B$1.35B
Property, plant and equipment, net$136.4M$218.4M$225.9M$165.5M$154.9M
Goodwill and intangible assets$1.04B$1.28B$1.59B$1.41B$1.41B
Long-term investments$45.6M$0.00$0.00$0.00$0.00
Total non-current assets$1.55B$1.82B$2.08B$1.79B$1.78B
Total assets$2.09B$2.42B$2.92B$2.89B$3.13B
Accounts payable$84.9M$100.9M$177.1M$373.3M$339M
Short-term debt$6.01M$6.2M$7.99M$8.09M$11.4M
Deferred revenue$106.8M$66.4M$20M$33.3M$157.1M
Total current liabilities$577.6M$545.8M$656.1M$857.9M$969.4M
Long-term debt$797.2M$1.09B$1.34B$852.9M$855.7M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$874.4M$1.16B$1.44B$986.8M$1B
Capital lease obligations$36.2M$41.9M$45.6M$17.5M$24.8M
Total liabilities$1.45B$1.71B$2.09B$1.84B$1.97B
Common stock$510K$510K$500K$500K$500K
Retained earnings$1.21B$1.3B$1.45B$1.24B$797M
Accumulated other comprehensive income (loss)$300K-$-10K-$-420K-$-940K-$-290K
Total equity$642.1M$706.6M$831.3M$1.04B$1.16B
Total investments$45.6M$0.00$0.00$0.00$0.00
Total debt$803.2M$1.1B$1.35B$861M$867.1M
Net debt$769.2M$1.09B$1.32B$796.4M$686.1M
Cash flow statement
20252024202320222021
Net income-$-95.7M-$-146.98M$210.7M$444.1M$327.4M
Depreciation and amortization$156.6M$173.8M$160.9M$137.1M$103.7M
Stock-based compensation$30.7M$23.3M$18M$30.1M$25.2M
Change in working capital$101M$85.9M-$-50.13M-$-560K-$-143.49M
Accounts receivable$74.8M$219.4M$224.9M$20M-$-585.27M
Inventory$0.00$0.00$0.00$0.00-$-256.12M
Accounts payable-$-20.57M$0.00$0.00$0.00$256.1M
Net cash provided by operating activities$269.5M$320.4M$372.2M$653.7M$305.4M
Investments in property, plant and equipment-$-35.63M-$-80.89M-$-103.69M-$-75.83M-$-53.66M
Acquisitions, net$65.3M$0.00-$-292.1M-$-69.5M-$-41.26M
Net cash used for investing activities$4.3M-$-79.94M-$-412.49M-$-170.71M-$-107.4M
Common stock issued$0.00$0.00$0.00$0.00$0.00
Common stock repurchased-$-2.09M-$-8.47M-$-424.74M-$-576.77M-$-2.69M
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-295.89M-$-259.45M$10.7M-$-591.87M-$-34.9M
Net change in cash-$-22.13M-$-18.97M-$-29.6M-$-108.84M$162.7M
Cash at end of period$67.2M$89.3M$108.3M$137.9M$246.7M
Operating cash flow$269.5M$320.4M$372.2M$653.7M$305.4M
Capital expenditure-$-35.63M-$-80.89M-$-105.39M-$-80.92M-$-53.66M
Free cash flow$233.8M$239.5M$266.8M$572.8M$251.7M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About AMN Healthcare Services, Inc.

        AMN Healthcare Services, Inc. (AMN) specializes in delivering comprehensive workforce solutions and staffing services to hospitals and healthcare facilities throughout the United States. Its operations are structured across three primary segments: The Nurse and Allied Solutions segment focuses on placing registered nurses in travel assignments, rapid response roles during emergencies or labor disruptions, and local positions. It also supplies allied health professionals for various roles and offers revenue cycle management solutions. Through its Physician and Leadership Solutions segment, AMN facilitates the placement of locum tenens physicians for temporary assignments, provides interim leadership for healthcare organizations, conducts executive searches, and handles permanent physician recruitment. Lastly, the Technology and Workforce Solutions segment encompasses services like language interpretation, vendor management systems (VMS), workforce optimization strategies, telehealth platforms, credentialing assistance, and various outsourced solutions. Beyond nurses and physicians, AMN's network of professionals includes a broad spectrum of allied health specialists such as physical, respiratory, and occupational therapists; medical and radiology technologists; lab technicians; speech pathologists; rehabilitation assistants; and pharmacists. The company leverages numerous recognized brands to deliver its services, including American Mobile, Nursefinders, NurseChoice, HealthSource Global Staffing, Onward Healthcare, O'Grady Peyton International, Med Travelers, Club Staffing, Staff Care, B.E. Smith, Merritt Hawkins, AMN Revenue Cycle Solutions, and AMN Language Services. Established in 1985, AMN Healthcare is headquartered in Dallas, Texas.

        CEO
        Caroline Sullivan Grace
        Employees
        2.66K
        Beta
        0.41

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of AMN Healthcare Services, Inc. (AMN)?

        AMN Healthcare Services, Inc. (AMN) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is AMN undervalued?

        AMN trades at a price of $35.68 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.